Commitments and Contingencies (Details Narrative)
|
|
|
1 Months Ended |
3 Months Ended |
12 Months Ended |
|
|
|
|
|
Aug. 11, 2021
USD ($)
shares
|
Aug. 01, 2021
USD ($)
shares
|
Apr. 15, 2021
USD ($)
|
Jan. 02, 2021
USD ($)
|
Mar. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
ft²
|
Dec. 31, 2020
USD ($)
|
Mar. 11, 2022
USD ($)
|
Dec. 27, 2021
USD ($)
$ / shares
shares
|
Nov. 25, 2020
shares
|
Jan. 01, 2020
USD ($)
|
| Commitments and Contingencies |
|
|
|
|
|
|
|
|
|
|
|
| Office Space | ft² |
|
|
|
|
|
1,250
|
|
|
|
|
|
| Product Development Facility Area | ft² |
|
|
|
|
|
8,517
|
|
|
|
|
|
| Contract Amount For Construction In Progress |
|
|
|
|
|
$ 670,000
|
|
|
|
|
|
| Outstanding Contract Amount For Construction In Progress |
|
|
|
|
|
464,000
|
|
|
|
|
|
| Monthly Salary |
$ 230,000
|
$ 12,000
|
$ 250,000
|
|
|
|
|
|
|
|
|
| Monthly Salary Equivalent To Taiwan Dollors |
$ 8,214
|
|
$ 8,929
|
|
|
|
|
|
|
|
|
| Annual Compensation In The Form Of Cash Percentage Range |
10-30
|
|
10-30
|
|
|
|
|
|
|
|
|
| Vesting Stock Options | shares |
|
500,000
|
|
|
|
|
|
|
|
|
|
| Bonus Of Shares | shares |
10,000
|
|
|
|
|
|
|
|
|
|
|
| Warrants Issued | shares |
|
|
|
|
|
|
|
|
|
452,617
|
|
| Non-convertible Note Issued Principal Amount |
|
|
|
|
|
|
|
$ 800,000
|
|
|
$ 84,000
|
| Converted Into Shares Of Common Stock | shares |
|
|
|
|
|
|
|
|
413,368
|
|
|
| Conversion Price Of Per Share | $ / shares |
|
|
|
|
|
|
|
|
$ 0.25
|
|
|
| Annual Salary |
|
|
|
$ 70,000
|
|
240,000
|
$ 240,000
|
|
|
|
|
| Shares Payable Quarterly Based On The Average Share Price |
|
|
|
$ 1,000
|
|
100,000
|
100,000
|
|
|
|
|
| Principal And Accrued Interest Amount |
|
|
|
|
|
|
|
|
$ 103,342
|
|
|
| Covid-19 Antigen Rapid Test Kits |
|
|
|
|
$ 386,412
|
$ 209,468
|
$ 0
|
|
|
|
|